Technical Analysis for ACRV - Acrivon Therapeutics, Inc.

Grade Last Price % Change Price Change
B 9.39 -10.91% -1.15
ACRV closed down 10.91 percent on Friday, April 19, 2024, on 69 percent of normal volume.
Earnings due: May 7
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Parabolic Rise Strength -10.91%
Wide Bands Range Expansion -10.91%
Upper Bollinger Band Touch Strength -10.91%
Multiple of Ten Bullish Other -9.19%
Wide Bands Range Expansion -9.19%
Calm After Storm Range Contraction -0.84%
NR7 Range Contraction -0.84%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 22 hours ago
Down 5% about 22 hours ago
Fell Below Previous Day's Low about 22 hours ago
Fell Below 10 DMA about 22 hours ago
Down 10% about 22 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops precision oncology medicines. The company's lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1/2 for use in the treatment of platinum-resistant ovarian cancer; endometrial and bladder cancer; and SCCs, including SCCHN, cervical, and anal cancer. It is also developing two preclinical drug programs used to predict tumor sensitivity based on custom OncoSignature tests. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Oncology Tumor Ovarian Cancer Bladder Cancer Gynaecological Cancer Anal Cancer

Is ACRV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.3
52 Week Low 3.19
Average Volume 915,121
200-Day Moving Average 7.23
50-Day Moving Average 6.02
20-Day Moving Average 8.04
10-Day Moving Average 9.46
Average True Range 1.18
RSI (14) 60.32
ADX 45.42
+DI 36.47
-DI 12.35
Chandelier Exit (Long, 3 ATRs) 8.35
Chandelier Exit (Short, 3 ATRs) 9.05
Upper Bollinger Bands 11.42
Lower Bollinger Band 4.65
Percent B (%b) 0.7
BandWidth 84.20
MACD Line 1.20
MACD Signal Line 1.07
MACD Histogram 0.1366
Fundamentals Value
Market Cap 208.4 Million
Num Shares 22.2 Million
EPS -2.26
Price-to-Earnings (P/E) Ratio -4.15
Price-to-Sales 0.00
Price-to-Book 0.57
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.90
Resistance 3 (R3) 12.08 11.42 11.48
Resistance 2 (R2) 11.42 10.79 11.33 11.34
Resistance 1 (R1) 10.41 10.39 10.08 10.23 11.20
Pivot Point 9.75 9.75 9.59 9.66 9.75
Support 1 (S1) 8.74 9.12 8.41 8.56 7.58
Support 2 (S2) 8.08 8.72 7.99 7.44
Support 3 (S3) 7.07 8.08 7.30
Support 4 (S4) 6.89